Biohaven Stock’s Wild Ride: Big Drops, Big Hopes as FDA Verdict Nears
In summary, Biohaven’s stock is a tale of high stakes in biotech. Recent price swings underscore the uncertainty, but also the potential reward if Biohaven’s bets pay off. With an FDA verdict